Objectives To determine sample sizes in studies on diagnostic accuracy and the proportion of studies that report calculations of sample size. Design Literature survey.
Introduction
Estimates of sensitivity and specificity in small studies on diagnostic accuracy are usually imprecise, with wide confidence intervals. This makes it difficult to assess just how informative a test may be. Subgroup analysis is often needed because sensitivity and specificity may vary across patient subgroups, yet estimates are even less precise when subgroups are considered. 1 Investigators should calculate the sample size needed for sufficiently narrow confidence intervals at the planning stages of a study, as is common practice for randomised trials. 2 3 For example, if a diagnostic test requires a sensitivity of at least 90% for adequate decision making, the lower boundary of the 95% confidence interval should be at least 90%.
We hypothesised that studies of diagnostic accuracy rarely report considerations of sample size and tend to be small. We assumed that authors would state calculations of sample size if they had been performed. We investigated study sizes, the number of subgroup analyses, and how often studies on diagnostic accuracy reported calculations of sample sizes.
Methods
Two reviewers independently screened all issues of the BMJ, Lancet, New England Journal of Medicine, and JAMA as well as four specialist journals (Thorax, Gastroenterology, American Journal of Obstetrics and Gynecology, and European Journal of Pediatrics) published in 2002 for studies on the accuracy of tests. From each full report we extracted data on the type of test(s) studied (table) , study sizes, the number of subgroup analyses, and how often the studies reported calculations of sample size. We calculated 95% confidence intervals, medians, and interquartile ranges.
Results
Fifty seven of 8999 articles reported test accuracy. Fourteen studies focused on a screening test and were excluded, which left 43 clinical studies for analysis. The median sample size was 118 (interquartile range 71-350) and the median prevalence was 43% (27-61%). The median number of patients with the target condition-needed to calculate a test's sensitivity-was 49 (28-91). The median number of patients without the target condition-needed to determine a test's specificity-was 76 (27-209).
Two of 43 studies (5%; 95% confidence interval 1.3% to 15.5%) reported a priori calculations of sample size, but no study reported that the sample size had been calculated on the basis of preplanned analyses of subgroups. Twenty articles (47%) reported results for subgroups of patients. The number of subgroups ranged from two to 19 (median four). Four studies used multivariable regression, but none used interaction terms.
Discussion
In this survey of studies on diagnostic accuracy in eight major journals, only 4.7% of the studies reported that they considered sample size. Analysing small numbers of participants with and without the target condition usually yields imprecise estimates of overall diagnostic accuracy, and even less precise estimates of subgroups. For example, when the number of patients with the target condition is 49 the two sided 95% confidence interval of a sensitivity of 81% (40 true positives) is 68% to 91%. 4 5 To ensure reasonably precise estimates of sensitivity and specificity investigators should consider sample sizes during the planning stages of the study. Investigators should calculate how precise the estimates of test accuracy should be for a particular diagnostic situation and report these calculations with confidence intervals. Arguably, sample size calculations are not important once data collection has been completed. 2 All that matters is the width of the confidence intervals. However, besides determining the minimum study size needed, calculations of sample size have another useful feature that remains important after the study has finished. These calculations require authors to think about the minimum precision needed for a test to be clinically meaningful. It is easier for readers to interpret reported confidence intervals if they have access to these data.
In conclusion, few studies on diagnostic accuracy report calculations of sample size. The number of participants in most studies on diagnostic accuracy is probably too small to analyse the variability of measures of accuracy across subgroups of patients. Most such studies are too small to provide precise estimates of the overall sensitivity and specificity of a test, let alone for subgroups, 1 and few studies have investigated this issue. We support the authors' recommendation that all diagnostic studies should calculate sample size at the planning phase, especially as straightforward methods are available for assessing simple proportions, such as sensitivity and specificity. However, they used the specificity and sensitivity of single tests to calculate sample size (understandable given the predominance of these tests in research) and did not consider the increasing number of clinically relevant studies that measure the accuracy of several tests in combination. 2 If you were testing the accuracy of B-type natriuretic peptide (BNP) for excluding heart failure in primary care, for example, precise estimation of the sensitivity and specificity of the test might seem important. Such tests, however, have limited value in clinical practice. Firstly, in daily practice positive and negative values merely help doctors to estimate the probability of disease. 3 Secondly, a diagnosis in practice is seldom based on one test. Doctors would probably use the BNP test only if it provided extra diagnostic information to other measures such as signs and symptoms, which have already been assessed. To improve clinical practice, it would be better to measure the diagnostic accuracy of combinations of readily available tests (applying multivariable regression analysis with receiver operating characteristic curves) and then assess whether the addition of BNP improves accuracy. 4 The BNP test should not be used when the patient's history and physical examination would provide equivalent diagnostic information.
We know even less about determinations of sample size for multivariable diagnostic studies. The number of tests studied is usually limited to allow for adequate data analysis. An often used rule is that at least 10 patients with the disease should be tested for each diagnostic test evaluated. 5 Such ways of determining sample size are not ideal. If the method suggested by Bachmann and colleagues is used to determine sample size in evaluations of multiple tests, many assumptions must be made to achieve acceptable proportions of false negative and false positive diagnoses when a cutoff value is introduced.
Methodological improvements are needed to guide considerations of sample size in diagnostic research. Lack of consensus on some of these issues is no excuse for "complete" lack of prior calculations of sample size in diagnostic studies. Bachmann and colleagues showed that a lack of such calculations is common. We hope that authors of studies on diagnostic tests will soon adopt more rigorous guidelines based on the standards for reporting of diagnostic accuracy (STARD initiative; www.consort-statement.org/Initiatives/newstard.htm).
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